Cargando…

P18-03. Dendritic cell-based immune therapy against HIV-1

Detalles Bibliográficos
Autores principales:	Gruters, RA, de Keersmaecker, B, de Goede, AL, Allard, SD, Koetsveld, J, Corthals, J, Schutten, M, Heirman, C, Ende, ME van der, Lacor, P, Osterhaus, AD, Thielemans, K, van Baalen, CA, Aerts, JL
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767818/ http://dx.doi.org/10.1186/1742-4690-6-S3-P312

Ejemplares similares

Clinical trials with MRNA electroporated dendritic cells for stage III/IV melanoma patients
por: Wilgenhof, Sofie, et al.
Publicado: (2015)

Phase II study of autologous mRNA electroporated dendritic cells (TriMixDC-MEL) in combination with Ipilimumab in patients with pretreated advanced melanoma
por: Thielemans, Kris, et al.
Publicado: (2014)

Characterization of CD8(+) T-Cell Responses in the Peripheral Blood and Skin Injection Sites of Melanoma Patients Treated with mRNA Electroporated Autologous Dendritic Cells (TriMixDC-MEL)
por: Benteyn, Daphné, et al.
Publicado: (2013)

TriMix and tumor antigen mRNA electroporated dendritic cell vaccination plus ipilimumab: link between T-cell activation and clinical responses in advanced melanoma
por: De Keersmaecker, Brenda, et al.
Publicado: (2020)

Single Domain Antibody-Mediated Blockade of Programmed Death-Ligand 1 on Dendritic Cells Enhances CD8 T-cell Activation and Cytokine Production
por: Broos, Katrijn, et al.
Publicado: (2019)

Impact of lenalidomide maintenance on the immune environment of multiple myeloma patients with low tumor burden after autologous stem cell transplantation
por: Fostier, Karel, et al.
Publicado: (2018)

mRNA: From a chemical blueprint for protein production to an off-the-shelf therapeutic
por: Van Lint, Sandra, et al.
Publicado: (2013)

Design of an Optimized Wilms' Tumor 1 (WT1) mRNA Construct for Enhanced WT1 Expression and Improved Immunogenicity In Vitro and In Vivo
por: Benteyn, Daphné, et al.
Publicado: (2013)

AZD1480 delays tumor growth in a melanoma model while enhancing the suppressive activity of myeloid-derived suppressor cells
por: Maenhout, Sarah K., et al.
Publicado: (2014)

iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy
por: de Jong, Wesley, et al.
Publicado: (2019)

Correction to: iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy
por: de Jong, Wesley, et al.
Publicado: (2019)

Intranodal administration of mRNA encoding nucleoprotein provides cross-strain immunity against influenza in mice
por: Joe, Patrick Tjok, et al.
Publicado: (2019)

Intralymphatic mRNA vaccine induces CD8 T-cell responses that inhibit the growth of mucosally located tumours
por: Bialkowski, Lukasz, et al.
Publicado: (2016)

Antibiotic prescriptions in the context of suspected bacterial respiratory tract superinfections in the COVID-19 era: a retrospective quantitative analysis of antibiotic consumption and identification of antibiotic prescription drivers
por: Van Laethem, J., et al.
Publicado: (2021)

Correction to: Antibiotic prescriptions in the context of suspected bacterial respiratory tract superinfections in the COVID-19 era: a retrospective quantitative analysis of antibiotic consumption and identification of antibiotic prescription drivers
por: Van Laethem, J., et al.
Publicado: (2023)

Dendritic cell immunotherapy followed by cART interruption during HIV-1 infection induces plasma protein markers of cellular immunity and neutrophil recruitment
por: van den Ham, Henk-Jan, et al.
Publicado: (2018)

Autologous dendritic cell vaccination against HIV-1 induces changes in natural killer cell phenotype and functionality
por: Laeremans, Thessa, et al.
Publicado: (2023)

Immunogenicity of targeted lentivectors
por: Goyvaerts, Cleo, et al.
Publicado: (2014)

CD8α(+) and CD8α(−) Subclasses of Dendritic Cells Direct the Development of Distinct T Helper Cells In Vivo
por: Maldonado-López, Roberto, et al.
Publicado: (1999)

Vaccine-induced enhancement of viral infections
por: Huisman, W., et al.
Publicado: (2009)

SARS-CoV-2 seroprevalence among employees of a university hospital in Belgium during the 2020 COVID-19 outbreak (COVEMUZ-study)
por: De Geyter, Deborah, et al.
Publicado: (2021)

Targeting the tumor microenvironment to enhance antitumor immune responses
por: Van der Jeught, Kevin, et al.
Publicado: (2014)

Intratumoral administration of mRNA encoding a fusokine consisting of IFN-β and the ectodomain of the TGF-β receptor II potentiates antitumor immunity
por: Van der Jeught, Kevin, et al.
Publicado: (2014)

Five years of monitoring for the emergence of oseltamivir resistance in patients with influenza A infections in the Influenza Resistance Information Study
por: Lina, Bruno, et al.
Publicado: (2018)

Development of the Nanobody display technology to target lentiviral vectors to antigen-presenting cells
por: Goyvaerts, C, et al.
Publicado: (2012)

Cortaillod 21.1.03 Techmeta 26.03.03 CMS SUPRA
Publicado: (2003)

The efficiency of Vpx-mediated SAMHD1 antagonism does not correlate with the potency of viral control in HIV-2-infected individuals
por: Yu, Hangxing, et al.
Publicado: (2013)

Particle-mediated Intravenous Delivery of Antigen mRNA Results in Strong Antigen-specific T-cell Responses Despite the Induction of Type I Interferon
por: Broos, Katrijn, et al.
Publicado: (2016)

Identification of MAGE-3 Epitopes Presented by HLA-DR Molecules to CD4(+) T Lymphocytes
por: Chaux, Pascal, et al.
Publicado: (1999)

SIVdrl detection in captive mandrills: are mandrills infected with a third strain of simian immunodeficiency virus?
por: van der Kuyl, Antoinette C, et al.
Publicado: (2004)

EXM-86-03: 13/03/1986
por: Malandain, E
Publicado: (1986)

Phase I clinical trial of an intranodally administered mRNA-based therapeutic vaccine against HIV-1 infection
por: Leal, Lorna, et al.
Publicado: (2018)

Ultra-Fast Analysis of Plasma and Intracellular Levels of HIV Protease Inhibitors in Children: A Clinical Application of MALDI Mass Spectrometry
por: van Kampen, Jeroen J. A., et al.
Publicado: (2010)

Correction: Ultra-Fast Analysis of Plasma and Intracellular Levels of HIV Protease Inhibitors in Children: A Clinical Application of MALDI Mass Spectrometry
por: van Kampen, Jeroen J. A., et al.
Publicado: (2010)

BSDCON '03.
por: Collective
Publicado: (2003)

The tumor-associated antigen RHAMM (HMMR/CD168) is expressed by monocyte-derived dendritic cells and presented to T cells
por: Willemen, Yannick, et al.
Publicado: (2016)

PW03-007 - NLRP3 genetic variants in Schnitzler’s syndrome
por: De Koning, HD, et al.
Publicado: (2013)

Cross-reactive immunity potentially drives global oscillation and opposed alternation patterns of seasonal influenza A viruses
por: Gatti, Lorenzo, et al.
Publicado: (2022)

Epistemology for interdisciplinary research – shifting philosophical paradigms of science
por: Boon, Mieke, et al.
Publicado: (2018)

P03.03. Facebook use and professionalism among CAM students
por: Hinck, G, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_sqinjevjgbb1bnks2ub6pm7saq